86 results

• Xarelto Antidote to Reverse Bleeding Problems May Have Been Found by Portola

  January 12, 2015

  Irvin Jackson

  Clinical trials have shown some success in the development for a Xarelto reversal agent, as manufacturers race to develop antidotes for blood thinners linked to deadly and uncontrollable bleeding problems.

• Long-Term Plavix Use Increase Death Risk, But Lowers Stent Heart Risks

  November 17, 2014

  Irvin Jackson

  FDA investigators and researchers say some blood thinners can prevent heart attacks in those with heart stents, but Plavix specifically is associated with an increased risk of death as well.

• Eliquis Reversal Agent May Be Available Before Antidote for Xarelto or Pradaxa

  October 6, 2014

  Irvin Jackson

  Eliquis could become the first of a new generation of blood thinners to have a reversal agent to stop potentially deadly bleeding events.

• Lawsuit Filed Over Abilify Childhood Diabetes Risk

  August 29, 2014

  Irvin Jackson

  The makers of Abilify face a child diabetes lawsuit from a woman who says she began taking the drug as a teenager and developed type 2 diabetes.

• Eliquis Pushed Amid Bleeding Problems with Xarelto, Pradaxa

  August 22, 2014

  Irvin Jackson

  The makers of the blood thinner Eliquis are pushing the drug directly on consumers despite the lack of a reversal agent for Eliquis bleeding events.

• Onglyza Heart Risks to be Reviewed by FDA

  February 12, 2014

  Irvin Jackson

  The FDA is investigating potential links between the diabetes drug Onglyza and heart failure, following a study late last year.